Back to News
Market Impact: 0.12

Are "Magnificent Seven" Stocks Still Worth Buying Going Into 2026?

AVGONFLXNVDAGOOGLAMZNMETATSLAAAPLMSFTNDAQ
Technology & InnovationMedia & EntertainmentAnalyst InsightsInvestor Sentiment & PositioningCompany Fundamentals
Are "Magnificent Seven" Stocks Still Worth Buying Going Into 2026?

A Dec. 22, 2025 video highlights seven "magnificent" stock picks along with Broadcom (AVGO) and Netflix, arguing most remain attractive heading into 2026; the presenter used stock prices from the Dec. 22 trading day. The piece promotes The Motley Fool's Stock Advisor service, citing historical recommendation performance (Netflix: $1,000 → $502,783 from a Dec. 17, 2004 pick; Nvidia: $1,000 → $1,126,057 from an Apr. 15, 2005 pick) and a reported Stock Advisor average return of 975% versus a 193% S&P 500 return as of Dec. 23, 2025. Disclosure notes the author (Neil Rozenbaum) holds positions in Alphabet, Amazon, Meta and Tesla; The Motley Fool holds/recommends numerous tech/media names (Alphabet, Amazon, Apple, Meta, Microsoft, Netflix, Nvidia, Tesla) and recommends Broadcom, with additional listed option positions on Microsoft.

Analysis

Market structure: The video reinforces a winner-take-most dynamic in AI, benefiting NVDA, AVGO (infrastructure and chips), MSFT and cloud vendors that capture incremental data-center spending. Streaming/media winners (NFLX) gain pricing power from differentiated content and ad tiers while legacy ad stacks face share pressure; expect gross margins to expand ~200–500bp for leading cloud/AI incumbents if data-center utilization rises 10–20% over 12–24 months. Risk-on flows from large-cap tech strength should tighten credit spreads and push equity-implied vols down 10–30% in the near term, pressuring option sellers and leveraged volatility plays. Risk assessment: Tail risks include antitrust/AI regulation (focused investigations within 6–18 months), a China/Taiwan geopolitical shock disrupting fabs (instantaneous supply shock with 30–50% pricing impact on GPUs), and macro weakness that cuts capex by >15% year-over-year. Immediate (days) impact is sentiment-driven; short-term (weeks–months) earnings and holiday-sub numbers will reprice multiples; long-term (12–36 months) exposure depends on cloud capex trajectory and competitive silicon adoption curves. Hidden dependency: AI revenue growth is tightly coupled to hyperscaler procurement cycles and foundry capacity — monitor TSMC lead times and order books. Trade implications: Direct plays — establish core 2–3% long NVDA and 1–2% long AVGO allocations for 12–24 months; finance by reducing 2–3% exposure to cyclicals/consumer discretionary. Pair trade — long AVGO (1.5%) vs short INTC (1.0%) to express pricing power vs legacy CPU commoditization; target relative outperformance of 15–25% in 12 months. Options — buy Jan 2027 LEAP calls on NVDA (12–18 month) sized 0.5–1% of portfolio or buy 9–12 month NFLX calls and sell near-term calls to lower cost; set stop-loss on options at 40% premium decay or delta <0.30. Sector rotation — overweight semis, cloud software, streaming; underweight cyclical retail and small-cap banks until credit spreads normalize. Contrarian angles: Consensus may underprice margin compression risk as competition and vertical integration (hyperscalers building chips) accelerates — if a hyperscaler announces in-house silicon roadmap within 6–12 months, re-rate multiples down 20–40%. Conversely, Broadcom’s diversified software+silicon model is underappreciated; a buyback/ M&A push could lift EPS by 10–15% if executed. Historical parallel: 2016–2018 GPU cycle showed rapid multiple expansion then mean reversion; protect gains with profit targets (30–50%) and tighten stops if shares rally >40% in 90 days. Monitor regulatory filings and hyperscaler chip announcements over next 90 days as primary catalysts that could invalidate theses.